Proton Beam Radiation Therapy for Central Nervous System (CNS) Germ Cell Tumors
Phase II Study of Proton Radiation Therapy for CNS Germ Cell Tumors: Evaluation of Acute and Late Side Effects
Sponsor: Dana-Farber Cancer Institute
A NA clinical study on Central Nervous System Germ Cell Tumor and Germ Cell Tumor, this trial is ongoing. The trial is conducted by Dana-Farber Cancer Institute and has accumulated 12 data snapshots since 2010. Oncology trials at this stage typically focus on safety, tolerability, and early efficacy signals.
Status Flow
Change History
12 versions recorded-
Feb 2026 — Present [monthly]
Active Not Recruiting NA
-
Nov 2025 — Feb 2026 [monthly]
Active Not Recruiting NA
Status: Unknown → Active Not Recruiting
-
Sep 2024 — Nov 2025 [monthly]
Unknown NA
-
Jul 2024 — Sep 2024 [monthly]
Unknown NA
Status: Unknown Status → Unknown
-
Feb 2023 — Jul 2024 [monthly]
Unknown Status NA
Status: Active Not Recruiting → Unknown Status
▶ Show 7 earlier versions
-
Feb 2021 — Feb 2023 [monthly]
Active Not Recruiting NA
-
Jan 2021 — Feb 2021 [monthly]
Active Not Recruiting NA
-
Sep 2019 — Jan 2021 [monthly]
Active Not Recruiting NA
-
Dec 2018 — Sep 2019 [monthly]
Active Not Recruiting NA
-
Jun 2018 — Dec 2018 [monthly]
Active Not Recruiting NA
-
Jun 2017 — Jun 2018 [monthly]
Active Not Recruiting NA
Status: Recruiting → Active Not Recruiting · Phase: PHASE2 → NA
-
Jan 2017 — Jun 2017 [monthly]
Recruiting PHASE2
First recorded
Jun 2010
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
No eligibility information available.
Contact Information
- Dana-Farber Cancer Institute
- Massachusetts General Hospital
- National Institutes of Health (NIH)
For direct contact, visit the study record on ClinicalTrials.gov .